🔎 Trials Near Me

Gara Jalqabaatti › Migreenii › Tennessee

Qorannoo klinikaalii Migreenii Tennessee keessatti

Qorannoo 8 Migreenii f Tennessee keessatti hirmaatuu jiru.

Magaalota Tennessee keessatti

Takkalaa qorannoo (Ingiliffa)

Study of EVO756 in Adults With Migraine

  • Campbell Clinical Research, Franklin
Namoota walitti qabaa jiraSadarkaa 2
Umuriin 18 hanga 64 · Saalaa hunda · Haaromfame 02-Onk-2026 · NCT07616128

MMA Embolization for Refractory Chronic Migraine

  • Semmes Murphey Foundation, Memphis
Namoota walitti qabaa jira
Umuriin 18 hanga 65 · Saalaa hunda · Haaromfame 25-Ful-2026 · NCT06735833

A Study of Oral Atogepant Tablets to Assess Adverse Events and Change in Disease Activity To Prevent Migraine in Participants Aged 12 to 17 Years

  • Access Clinical Trials Inc /ID# 270280, Nashville
Namoota walitti qabaa jiraSadarkaa 3
Umuriin 12 hanga 17 · Saalaa hunda · Haaromfame 22-Ful-2026 · NCT06810505

Responding With Evidence and Access for Childhood Headaches

  • University of Tennessee Health Science Center/ LeBonheur Children's Hospital, Memphis
Namoota walitti qabaa jira
Umuriin 10 hanga 17 · Saalaa hunda · Haaromfame 21-Ful-2026 · NCT05889624

Comparative Effectiveness of Migraine Preventive Medications: The APT Comparison Study

  • Vanderbilt Medical Center, Nashville
Namoota walitti qabaa jiraSadarkaa 4
Umuriin 18 hanga 70 · Saalaa hunda · Haaromfame 16-Ful-2026 · NCT06972056

Study to Assess Adverse Events and Disease Activity of Oral Ubrogepant Tablets for the Acute Treatment of Migraine in Children and Adolescents (Ages 6-17)

  • Access Clinical Trials, Inc. /ID# 228002, Nashville
Namoota walitti qabaa jiraSadarkaa 3
Umuriin 6 hanga 17 · Saalaa hunda · Haaromfame 14-Ful-2026 · NCT05125302

Study Evaluating the Efficacy, Safety, and Tolerability of ASY202 (Dihydroergotamine Mesylate [DHE] Inhalation Powder Delivered Via a Multidose Dry Powder Inhaler) for the Acute Treatment of Migraine in Adult Patients

  • Clinical Research Associates, Inc., Nashville
Namoota walitti qabaa jiraSadarkaa 2
Umuriin 18 hanga 65 · Saalaa hunda · Haaromfame 02-Ful-2026 · NCT07646613

A Study to Evaluate the Efficacy and Safety of Elismetrep (K-304) in the Acute Treatment of Migraine

  • WR-ClinSearch, LLC, Chattanooga
  • Access Clinical Trials, Inc, Nashville
  • Clinical Research Associates, Inc., Nashville
Namoota walitti qabaa jiraSadarkaa 3
Umuriin 18 hanga 75 · Saalaa hunda · Haaromfame 20-Hag-2026 · NCT07645924

Kanneen ClinicalTrials.gov irraa argaman, daataa 06-Onk-2026 irratti argame. Qorannoon hundi isaa kan ofii qajeelfama qoodfannaa qaba; gareen qorannoo eenyu akka hirmaatu murteessa.